drugset / Trial / NCT00573066

Understanding Dexmedetomidine In Infants Post-Operative From Cardiac Surgery

NCT00573066

Phase 1 Completed 56 enrolled Athena Zuppa
NaSingle-groupOpen-labelTreatment

Summary

This study is being conducted to determine what dexmedetomidine does to the body and in turn, what how the body handles the medication. This medication, for the purpose of this trial, is used as a short-term sedative for infants who are immediately post-operative from cardiac surgery and have a breathing tube and are breathing with the assistance of a mechanical ventilator or breathing machine.

Timeline

Start
2004-05
Primary completion
2006-10
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.25 ug/kg
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg
Subject Dexmedetomidine Other / unclassified 0.75 ug/kg